KNCV Tuberculosis Foundation
KNCV Tuberculosis Foundation is an international non-profit organization dedicated to the fight against tuberculosis (TB), still the deadliest infectious disease in the world. KNCV is an international center of expertise for TB control that promotes effective, efficient, innovative and sustainable tuberculosis control strategies in a national and international context. We are an organization of passionate TB professionals, including doctors, researchers, training experts, nurses and epidemiologists. We aim to stop the spread of the worldwide epidemic of TB and to prevent the further spread of drug-resistant TB.
Background
Latent tuberculosis (TB) infection (LTBI) is the seed bed for developing TB disease and continued transmission. It’s estimated that a quarter of the world’s population is latently infected with TB. WHO policy to give at least six months of isoniazid preventive therapy (IPT) to people living with HIV (PLHIV) and child contacts has existed since 1993, yet the uptake of IPT in high burden countries remains poor. A short-course regimen of isoniazid and rifapentine weekly for three months (3HP) is now available. 3HP is associated with less toxicity, better adherence and similar efficacy to IPT and may be logistically easier for programs to scale up. WHO has included scaling up TB preventive therapy, particularly short-course regimens, in its End TB strategy. Implementation of 3HP will meet the same fate as IPT unless existing
barriers to its supply, adoption, demand and delivery are removed. In order to demonstrate that it’s possible to scale-up the uptake of preventive therapy a consortium initiated the IMPAACT4TB project.
The IMPAACT4TB consortium is led by the Aurum Institute with core partners Clinton Health Access Initiative, Johns Hopkins University, KNCV Tuberculosis Foundation and the Global Drug Facility. Our consortium has exceptional experience in shaping markets, strengthening supply chain management and supporting National TB Programs in high burden countries.
The goal of IMPAACT4TB is to reduce TB incidence among PLHIV and child contacts<15 living in low and middle income countries by contributing to the sustainable scale up of 3HP preventive therapy. The project will utilize the UNITAID grant to start 400,000 people on 3HP and catalyze an increase in supply, demand for and uptake of 3HP in focus countries with the outcome of starting >1 million child contacts and PLHIV on 3HP. The strategy (outputs) is to leverage each partners’ complementary skills, networks and in-country presence to address barriers to supply; adoption; demand and delivery of 3HP. KNCV is leading the implementation process in Ethiopia, Tanzania, Malawi and Indonesia.
Purpose of the position
The overall purpose of the position will be to regularly collect and enter quality client related data for enhanced M&E from sentinel site using the REDCap database, maintaining strict data security and privacy. Moreover, provide routine IT support and other M&E support in coordination with the Senior M&E Officer.
Position in the organization
The Data Collector will report directly to the Senior M&E Officer, and will maintain close communication and coordination to the IMPAACT4TB Project Manager.
Duties and responsibilities
The IMPAACT4TB Data Collector will:
What does KNCV Tuberculosis Foundation offer?
Who are we looking for?
Education
Knowledge/Experience